As discussed many times, big pharmas may be watching, but they typically wait to invest after proof of concept. Post Phase 2b trial results would be a more realistic timeframe for them.
Too true, kbear. I can still recall Cephalon pumping $220 million into Mesoblast following extremely positive Phase 2 clinical data (for congestive heart failure and hematopoietic stem cell transplants).
In addition, Acrux received a deal worth $335 million from Eli Lilly following positive Phase 3 clincial results for Axiron (testosterone replacement therapy applied to the underarm).
If all goes well, it's only a matter of which of the Big Phrma come knocking - and how much it means in terms of commercial dollars and subsequent SP rise.
As discussed many times, big pharmas may be watching, but they...
-
- There are more pages in this discussion • 275 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.015(4.92%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.5¢ | 30.0¢ | $1.168M | 3.702M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 148547 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 51809 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |